- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Health-professional website page combined a licensed product with pipeline products and implied they were “effective, high quality”. PMCPA…
PMCPA case summary: Director v Merck Sharp & Dohme (AUTH/3086/9/18). Case text not provided in CASE_TEXT, so details…
Efient leavepiece used prominent 15‑month subgroup/landmark data and downplayed overall bleeding risk. PMCPA ruled it misleading, inconsistent with…
Baxter UK was ruled in breach of Clause 9.1 after exhibiting at a Northern Ireland urology meeting held…
A hospital doctor said GSK’s ‘do more, feel better, live longer’ strapline on a BTS stand invitation implied…
Anonymous prescriber alleged GSK hid asthma pneumonia risk in Relvar promotion and cherry-picked COPD comparisons. PMCPA Panel found…
Janssen admitted a Crohn’s awareness campaign sent to UK gastroenterologists promoted ustekinumab for an unlicensed indication and was…
PV consultant alleged off-label exacerbation-risk promotion for Ultibro. Panel found breaches for a FLAME “business card” and unclear…
Lilly challenged a Levemir advertorial in Pulse. PMCPA found the “Weight advantages with Levemir” section misleading/ambiguous and inconsistent…
Servier rep’s proactive call rate exceeded Code limits and biscuits/snacks were used to gain access. Panel found breaches…
One real case. One key lesson. Every week — free.